Highlights

• Ramsay Health Care fell 0.23% to $51.68 on 4 September 2026

• FY26 total Revenue and other income reached A$9.276 billion, up 5.4%

• EBITDA increased 4.2% to A$1.069 billion and EBIT rose 2.9% to A$298.6 million

• Group net loss after tax was A$50.5 million, though underlying NPAT rose 23% in constant currency

Ramsay Health Care Ltd (ASX:RHC) edged marginally lower by 0.23% to $51.68 on 4 September 2026. The hospital operator continues to navigate a complex operating environment, with its FY26 results showing solid top-line growth but a statutory net loss weighing on investor sentiment.

About the Company

Ramsay Health Care is one of the world's largest private hospital operators, with a network of hospitals across Australia, Europe and Asia. Headquartered in Sydney, the company operates over 460 facilities globally and provides a broad spectrum of healthcare services including surgical, medical, mental health and day surgery. Ramsay has faced challenges in recent years from rising labour costs, insurance funding pressures and structural changes in healthcare delivery, but remains a significant presence in Australian and international private healthcare markets.

Key Developments

For FY26, Ramsay Health Care reported total revenue and other income of A$9.276 billion for its consolidated group, up 5.4%, while EBITDA increased 4.2% to A$1.069 billion and EBIT rose 2.9% to A$298.6 million. Group net loss after tax was A$50.5 million. Underlying NPAT increased 23% in constant currency.

Key Catalysts to Watch

• Recovery in surgical volumes and hospital utilisation rates

• Progress on cost efficiency and labour productivity programs

• Any strategic announcements regarding the European operations

• Improvement in insurance funding and private health premium increases

Risks

• Labour cost Inflation continuing to pressure hospital margins

• Ongoing pressure on private Health Insurance participation rates

• Statutory net loss position and Debt levels

• Regulatory changes to private hospital funding or health insurance rules

Conclusion

Ramsay Health Care's FY26 results reflect a Business making gradual progress amid a challenging operating environment. Revenue and EBITDA growth are encouraging, but the statutory net loss remains a concern for income-focused investors. The 23% rise in underlying NPAT in constant-currency terms offers some optimism about the underlying business trajectory. The stock's modest dip on 4 September suggests the market remains cautious but not alarmed. Recovery in surgical volumes and cost discipline will be the key watchpoints heading into FY27.